Ischemic preconditioning is the phenomenon whereby brief periods of sublethal ischemia protect against a subsequent, more prolonged, ischemic insult. In remote ischemic preconditioning, ischemia to one organ protects other organs at a distance. Olenchock et al created mouse models to ask if inhibition of the alpha-ketoglutarate-dependent dioxygenase Egln1, which senses oxygen and regulates the hypoxia-inducible factor transcription factor, could suffice to mediate local and remote ischemic preconditioning.
Using somatic gene deletion and a pharmacological inhibitor, they found that inhibiting Egln1 systemically or in skeletal muscles protects mice against myocardial ischemia-reperfusion injury.
Read the full Concise Critical Appraisal by logging into the SCCM eCommunity. Concise Critical Appraisal is a regular feature aimed at highlighting the best and most relevant literature from a variety of academic journals and encouraging discussion around recent studies and research.